Wako Pure Chemical Industries Ltd.

Of the many other small-to-medium scale medtech deals in 2016, the more eye-catching were:

2016 was a quiet year in terms of transformational mergers and acquisitions in Japan, with nothing that could be considered a “mega-deal” clinched during the calendar period. Astellas Pharma Inc.